메뉴 건너뛰기




Volumn 113, Issue 1, 2001, Pages 103-114

Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

Author keywords

Childhood lymphoblastic leukaemia; Prognosis

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

EID: 0035021732     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02668.x     Document Type: Article
Times cited : (112)

References (43)
  • 17
    • 0031875371 scopus 로고    scopus 로고
    • Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI)
    • Medical Research Council Childhood Leukaemia Working Party
    • (1998) Leukemia , vol.12 , pp. 1249-1255
    • Hann, I.M.1    Richards, S.M.2    Eden, O.B.3    Hill, F.G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.